Evidence map›Paper›PMID 33437161›Full record

ArticleJournal of ginseng research2021

Acremonidin E produced by

Kyuri Kim, Hae-In Jeong, Inho Yang, Sang-Jip Nam, Kyung-Min Lim

Abstract read
In one paragraph

Article in Journal of ginseng research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Silver Carp (Nutrients · 2023
    Article
  6. Heat-KilledAntioxidants (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kyuri KimCollege of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.
Hae-In JeongDepartment of Chemistry and Nanoscience, Global Top 5 Program, Ewha Womans University, Seoul, Republic of Korea.
Inho YangDepartment of Convergence Study on the Ocean Science and Technology, Korea Maritime and Ocean University, Busan, Republic of Korea.
Sang-Jip NamDepartment of Chemistry and Nanoscience, Global Top 5 Program, Ewha Womans University, Seoul, Republic of Korea.
Kyung-Min LimCollege of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGinseng extracts and ginseng-fermented products are widely used as functional cosmetic ingredients for their whitening and antiwrinkle effects. Recently, increasing attention has been given to bioactive metabolites isolated from endophytic fungi. However, little is known about the bioactive metabolites of the fungi associated with

methodsAn endophytic fungus,

resultsAcremonidin E reduced melanogenesis in α-melanocyte-stimulating hormone (α-MSH)-stimulated B16F10 cells with minimal cytotoxicity. qRT-PCR analysis demonstrated that acremonidin E downregulated melanogenic genes, including tyrosinase and tyrosinase-related protein 1 (TRP-1), while their enzymatic activities were unaffected. The antimelanogenic effects of acremonidin E were further confirmed in MNT-1 and a pigmented 3D human epidermal skin model, Melanoderm. Immunohistological examination of the Melanoderm further confirmed the regression of both melanin synthesis and melanocyte activation in the treated tissue.

conclusionThis study demonstrates that acremonidin E, a bioactive metabolite derived from a fungal endophyte of

Indexed as

Acremonidin EEndophytic fungusMelanogenesisPanax ginsengPenicillium sp. SNF12

Identifiers

PMID33437161
PMCPMC7790906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.